Ultragenyx Pharmaceutical (RARE) Q1 2018 Earnings

20FebConfirmed
Q2 2017
Q3 2017
Q4 2017
Q1 2018
-2.04
-1.9
-1.77
-1.63

Details

Expected EPS
-2.04
Actual EPS
-1.89
Surprise EPS
0.15
Surprise Percent
+7.35%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.89 per share for Q1 2018.

0 Comments

Share your thoughts